Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-14

Clinical Trial Update: Treatment With Intravitreal Avastin for Large Uveal Melanomas [NA]

View source ↗

Summary

A completed clinical trial update reported results for intravitreal bevacizumab (Avastin) in large uveal melanomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Uveal Melanoma | NA | Status: COMPLETED | Results posted: 2015-04-14